Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where therapy alternatives remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/xrp-lawsuit-due-to-settle-in-may-as-ripple-whales-add-dtx-for-10x-gains/